TIGD1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the t-SNE plots presented in Figure S1 depict TIGD1 expression patterns in single-cell populations derived from a variety of cancers, including ALL, AML, astrocytoma (AST), breast invasive carcinoma (BRCA), chronic myeloid leukemia (CML), glioblastoma multiforme (GBM), glioma, high-grade glioma (HGG), head and neck squamous cell carcinoma (HNSCC), LUAD, melanoma (MEL), oligodendroglioma (ODG), RB, RCC, and UM.